Longitudinal diastolic strain slope as an early sign for systolic dysfunction among patients with active cancer



Diastolic dysfunction is a common finding in patients receiving cancer therapy. This study evaluated the correlation of diastolic strain slope (Dss) with routine echocardiography diastolic parameters and its role in early detection of systolic dysfunction and cardiovascular (CV) mortality within this population.


Data were collected from the Israel Cardio-Oncology Registry (ICOR), a prospective registry enrolling adult patient receiving cancer therapy. All patients performed at least three echocardiography exams (T1, T2, T3), including left ventricle Global Longitudinal Strain (LV GLS) and Dss. Systolic dysfunction was determined by either LV GLS relative reduction of ≥ 15% or LV ejection fraction reduction > 10% to < 53%. Dss was assessed as the early lengthening rate, measured by the diastolic slope (delta%/sec).


Among 144 patients, 114 (79.2%) were female with a mean age of 57.31 ± 14.3 years. Dss was significantly correlated with e' average. Mid segment Dss change between T1 and T2 showed significant association to systolic dysfunction development (Odds Ratio (OR) = 1.04 [1.01,1.06]. p = 0.036). In multivariate prediction, Dss increase was a significant predictor for the development of systolic dysfunction (OR = 1.06 [1.03,1.1], P < 0.001).An 8% increase in Dss between T1 and T2 was associated with a trend in increased CV mortality (HR = 3.4 [0.77,15.4], p = 0.085).


This study is the first to use the novel measurement of Dss in patients treated with cancer therapies and to show significant correlation between routine diastolic dysfunction parameters and Dss. Changes in the mid segment were found to have significant independent early predictive value for systolic dysfunction development in univariate and multivariate analyses.

Graphic abstract

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3


  1. 1.

    Tilemann LM, Heckmann MB, Katus HA, Lehmann LH, Müller OJ (2018) Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome. Clin Res Cardiol 107(4):271–280

    Article  Google Scholar 

  2. 2.

    Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64

    Article  Google Scholar 

  3. 3.

    Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of echocardiography and the European Association of cardiovascular imaging. J Am Soc Echocardiogr 27(2):911–939

    Article  Google Scholar 

  4. 4.

    Swain SM, Whaley FS, Ewer MS (2003) Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 91:2869–2879

    Article  Google Scholar 

  5. 5.

    Sawaya H, Seba IA, Plana JC, Januzzi JL, Ky B, Cohen V et al (2011) Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 107:1375–1380

    CAS  Article  Google Scholar 

  6. 6.

    Yoon HJ, Kim KH, Kim HY, Park H, Cho JY, Hong YJ, Park HW, Kim JH, Ahn Y, Jeong MH, Cho JG, Park JC (2019) Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer. Clin Res Cardiol 10:15

    Google Scholar 

  7. 7.

    Santoro C, Aripino G, Esposito R, Lembo M, Paciolla I, Cardalesi C, Simone GD, Trimarco B, Placido SD, Galderisi M (2017) 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility. Eur Heart Jl-Cardiovasc Imaging 18:930–936

    Article  Google Scholar 

  8. 8.

    Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, DeGiacomi G, Rubino M, Veglia F, Fiorentini C, Cipolla CM (2010) Anthracycline induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55:213–220

    CAS  Article  Google Scholar 

  9. 9.

    Wadhwa D, Fallah-Rad N, Grenier D, Krahn M, Fang T, Ahmadie R, Walker JR, Lister D, Arora RC, Barac L, Morris A, Jassal DS (2008) Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study. Breast Cancer Res Treat 117:357–364

    Article  Google Scholar 

  10. 10.

    Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC (2012) Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 5:596–603

    Article  Google Scholar 

  11. 11.

    Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiography 23:351–369

    Article  Google Scholar 

  12. 12.

    Zamorano JL, Lancellotti P, Muñoz DR, Aboyans V, Asteggiano R, Galderisi M et al (2016) (2016) ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 37:2768–3280

    Article  Google Scholar 

  13. 13.

    Upshaw JN, Finkelman B, Hubbard RA et al (2020) Comprehensive assessment of changes in left ventricular diastolic function with contemporary breast cancer therapy. J Am Coll Cardiol Img 13(1):198–210

    Article  Google Scholar 

  14. 14.

    Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533

    CAS  Article  Google Scholar 

  15. 15.

    Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794

    CAS  Article  Google Scholar 

  16. 16.

    Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, Nagueh SF (2004) Optimal non-invasive assessment of LV filling pressures: a comparison of tissue Doppler echocardiography and BNP in patients with pulmonary artery catheters. Circulation 109:2432–2439

    Article  Google Scholar 

  17. 17.

    Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of cardiovascular imaging. J Am Soc Echocardiogr 29(4):277–314

    Article  Google Scholar 

  18. 18.

    Ersbøll M, Andersen MJ, Valeur N, Mogensen UM, Fahkri Y, Thune JJ et al (2014) Early diastolic strain rate in relation to systolic and diastolic function and prognosis in acute myocardial infarction: a two-dimensional speckle-tracking study. Eur Heart J 35(10):648–656

    Article  Google Scholar 

  19. 19.

    Lassen MCH, Biering-Sørensen SR, Olsen FJ, Skaarup KG, Tolstrup K, Qasim AN et al (2019) Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population. Eur Heart J 40(6):518–525

    Article  Google Scholar 

  20. 20.

    Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF (2007) Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation 115(11):1376–1383

    Article  Google Scholar 

  21. 21.

    Lee JH, Park JH (2018) Strain analysis of the right ventricle using two-dimensional echocardiography. J Cardiovasc Imaging 26(3):111–124

    Article  Google Scholar 

  22. 22.

    Choudhury A, Magoon R, Malik V, Kapoor PM, Ramakrishnan S (2017) Studying diastology with speckle tracking echocardiography: the essentials. Ann Card Anaesth 20(Supplement):S57–S60

    PubMed  PubMed Central  Google Scholar 

  23. 23.

    Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S (2006) Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1175–1181

    Article  Google Scholar 

  24. 24.

    Perk G, Tunick PA, Kronzon I (2007) Non-Doppler two-dimensional strain imaging by echocardiography—from technical considerations to clinical applications. J Am Soc Echocardiogr 20:234–243

    Article  Google Scholar 

  25. 25.

    Park JH, Marwick TH (2011) Use and limitations of E/e’ to assess left ventricular filling pressure by echocardiography. J Cardiovasc Ultrasound 19(4):169–173

    Article  Google Scholar 

  26. 26.

    AlJaroudi WA, Thomas JD, Rodriguez LL, Jaber WA (2014) Prognostic value of diastolic dysfunction: state of the art review. Cardiol Rev 22(2):79–90

    Article  Google Scholar 

  27. 27.

    Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202

    Article  Google Scholar 

  28. 28.

    Stoddard MF, Seeger J, Liddell NE, Hadley TJ, Sullivan DM, Kupersmith J (1992) Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 20:62–69

    CAS  Article  Google Scholar 

  29. 29.

    Nagiub M, Nixon JV, Kontos MC (2018) Ability of nonstrain diastolic parameters to predict doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis. Cardiol Rev 26:29–34

    Article  Google Scholar 

  30. 30.

    Klein R, Nadouri D, Osler E, Johnson C, Dent S, Dwivedi G (2019) Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy. Nucl Med Commun 40:22–29

    CAS  Article  Google Scholar 

  31. 31.

    Reuvekamp EJ, Bulten BF, Nieuwenhuis AA (2016) Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA). J Nucl Cardiol 23:824–832

    CAS  Article  Google Scholar 

  32. 32.

    Lange SA, Ebner B, Wess A, Kogel M, Gajda M, Hitschold T, Jung J (2012) Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy. Clin Res Cardiol 101:415–426

    CAS  Article  Google Scholar 

  33. 33.

    Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, Douglas PS, Bhatia S, Chao C (2016) Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol 34(10):1122–1130

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Michal Laufer-Perl.

Ethics declarations

Conflict of interest

The author declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (JPG 345 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hochstadt, A., Arnold, J., Rosen, R. et al. Longitudinal diastolic strain slope as an early sign for systolic dysfunction among patients with active cancer. Clin Res Cardiol (2020). https://doi.org/10.1007/s00392-020-01776-w

Download citation


  • Diastolic strain
  • Cardio-oncology
  • Cardiotoxicity
  • GLS
  • Systolic dysfunction